New therapies in sepsis.
Vincent
J L
JL
Department of Intensive Care, Erasme University Hospital, Free University of Brussels, Belgium.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D004731:Endotoxins / Q000037:antagonists & inhibitors; D006801:Humans; D007167:Immunotherapy; D018124:Receptors, Tumor Necrosis Factor / Q000037:antagonists & inhibitors; D018805:Sepsis / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D012772:Shock, Septic / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D015996:Survival Rate; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000893:Anti-Inflammatory Agents; D004731:Endotoxins; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha